# Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI

> **NCT03301155** · PHASE4 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 1036 (actual)

## Conditions studied

- Preventive Medicine

## Interventions

- **DRUG:** Anaferon for children
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03301155
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-03
- **Primary completion:** 2019-05-20
- **Final completion:** 2019-05-20
- **Target enrollment:** 1036 (ACTUAL)
- **Last updated:** 2020-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03301155

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03301155, "Clinical Trial of Anaferon for Children Efficacy in Prevention of Influenza and Other ARVI". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT03301155. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*